SLDB

Solid Bioscience

7.38

+0.18+2.50%

Pre Market: 7.04 -0.34 -4.61%04:01 04/02 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE7.28/7.20

TODAY RANGE7.25-7.63

VOL3

MARKET CAP726.13M

52 WEEK RANGE2.410-8.72

AVG VOL (3M)1.36M

% TURNOVER0.92%

TURNOVER--

P/E (TTM)-3.7044

% RANGE5.21%

EPS(TTM)-1.9922

P/E(FORWARD)-4.7006

P/B3.238

BVPS2.280

DIVIDEND--

P/S11.93

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP480.09M

SHARES OUTSTANDING98.39M

NEXT EARNINGS05/13-05/18

FREE FLOAT65.05M

LOT SIZE1

EX-DATE10/28/2022

News

Press Releases

Financial Reports

Profile

Dow Jones·03/25 14:44
Solid Biosciences Is Maintained at Overweight by JP Morgan
Dow Jones·03/25 14:44
Solid Biosciences Price Target Raised to $12.00/Share From $11.00 by JP Morgan
TipRanks·03/25 11:16
J.P. Morgan Issues a Buy Rating on Solid Biosciences (SLDB)
TipRanks·03/25 11:05
Solid Biosciences price target raised to $12 from $11 at JPMorgan
TipRanks·03/23 15:07
3 Best Stocks to Buy Today, 3/23/2026, According to Top Analysts
TipRanks·03/23 12:50
Analysts Offer Insights on Healthcare Companies: Beta Bionics, Inc. (BBNX), Apogee Therapeutics (APGE) and Solid Biosciences (SLDB)
Dow Jones·03/23 10:31
Solid Biosciences Price Target Maintained With a $20.00/Share by HC Wainwright & Co.
TipRanks·03/23 10:16
Solid Biosciences: Strong SGT-003 Clinical Profile, Emerging Pipeline, and Robust Cash Runway Underpin Buy Rating
TipRanks·03/21 06:01
Evolving Tax Rules and New Excise Levies Threaten Solid Biosciences’ Profitability and Cash Flows
Seeking Alpha·03/20 14:24
Solid Bio wins new Buy at Guggenheim on lead asset
Dow Jones·03/20 12:50
Solid Biosciences Price Target Announced at $26.00/Share by Guggenheim
Dow Jones·03/20 12:21
Solid Biosciences Is Maintained at Buy by Chardan Capital
Dow Jones·03/20 12:21
Solid Biosciences Price Target Maintained With a $15.00/Share by Chardan Capital
TipRanks·03/20 12:20
Analysts Offer Insights on Healthcare Companies: Eledon Pharmaceuticals (ELDN), Hims & Hers Health (HIMS) and Solid Biosciences (SLDB)
TipRanks·03/20 11:20
Guggenheim starts Solid Biosciences with a Buy on DMD gene therapy potential

Same Industry

Name/Symbol

Change%

Price

SLDB

Regeneron Pharmaceuticals

REGN

-2.51%

737.71

GRDX

BIONTECH

BNTX

-2.04%

85.68

United Therapeutics Corp.

UTHR

-1.82%

522.83

Vertex Pharmaceuticals Inc

VRTX

+2.33%

443.16

Siga Technologie

SIGA

+6.85%

5.30

Moderna

MRNA

-2.68%

48.23

Charles Riv Labs Intl Inc

CRL

+1.96%

175.88

MEDP

Talphera Inc

TLPH

-4.03%

0.7415

ICON PLC

ICLR

+3.59%

105.74

CBPO

Iqvia Hldgs Inc

IQV

+1.08%

172.38

MOLN

Gilead Sciences Inc

GILD

+1.56%

136.34

ARCT

PRAH

Incyte Corp

INCY

+1.36%

95.40

Aptevo Therapeutics Inc

APVO

-7.26%

3.960

BSTC

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.